Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun Han

Showing results (731-740 of 785) with videos related to

Pageof 79
Sort By:
JNCI Cancer Spectrum|January 14, 2021
Risk Factors and Incidence of Colorectal Cancer According to Major Molecular SubtypesLiang Wang, Xiaosheng He, Tomotaka Ugai, et al.
Frontiers in Immunology|November 9, 2023
The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trialQian Qiao, Chun Han, Sisi Ye, et al.
Optics Letters|November 16, 2018
Further emission efficiency improvement of a commercial-quality light-emitting diode through surface plasmon couplingChun-Han Lin, Chia-Ying Su, Yu-Feng Yao, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 21, 2019
Evidence-based approaches to the application of precautionary allergen labelling: Report from two iFAAM workshopsAudrey DunnGalvin, Graham Roberts, Sabine Schnadt, et al.
BMC Cancer|May 1, 2019
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocolChen Li, Xiaomin Wang, Xin Wang, et al.
British Journal of Cancer|October 20, 2023
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trialXue Meng, Anping Zheng, Jun Wang, et al.
British Journal of Cancer|June 17, 2022
Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohortsXiao Luo, Wanshui Yang, Amit D Joshi, et al.
Regulatory Toxicology and Pharmacology : RTP|March 23, 2010
Food allergy: stakeholder perspectives on acceptable riskCharlotte B Madsen, René Crevel, Chun-Han Chan, et al.
BMC Cancer|May 25, 2019
Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocolChen Li, Xiaomin Wang, Xin Wang, et al.
Optics Express|December 25, 2015
Multi-mechanism efficiency enhancement in growing Ga-doped ZnO as the transparent conductor on a light-emitting diodeYu-Feng Yao, Chun-Han Lin, Chieh Hsieh, et al.
Pageof 79

Showing results (731-740 of 785) with videos related to

Sort By:
Pageof 79
JNCI Cancer Spectrum|January 14, 2021
Risk Factors and Incidence of Colorectal Cancer According to Major Molecular SubtypesLiang Wang, Xiaosheng He, Tomotaka Ugai, et al.
Frontiers in Immunology|November 9, 2023
The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trialQian Qiao, Chun Han, Sisi Ye, et al.
Optics Letters|November 16, 2018
Further emission efficiency improvement of a commercial-quality light-emitting diode through surface plasmon couplingChun-Han Lin, Chia-Ying Su, Yu-Feng Yao, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 21, 2019
Evidence-based approaches to the application of precautionary allergen labelling: Report from two iFAAM workshopsAudrey DunnGalvin, Graham Roberts, Sabine Schnadt, et al.
BMC Cancer|May 1, 2019
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocolChen Li, Xiaomin Wang, Xin Wang, et al.
British Journal of Cancer|October 20, 2023
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trialXue Meng, Anping Zheng, Jun Wang, et al.
British Journal of Cancer|June 17, 2022
Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohortsXiao Luo, Wanshui Yang, Amit D Joshi, et al.
Regulatory Toxicology and Pharmacology : RTP|March 23, 2010
Food allergy: stakeholder perspectives on acceptable riskCharlotte B Madsen, René Crevel, Chun-Han Chan, et al.
BMC Cancer|May 25, 2019
Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocolChen Li, Xiaomin Wang, Xin Wang, et al.
Optics Express|December 25, 2015
Multi-mechanism efficiency enhancement in growing Ga-doped ZnO as the transparent conductor on a light-emitting diodeYu-Feng Yao, Chun-Han Lin, Chieh Hsieh, et al.
Pageof 79